NEW YORK, NY -- (MARKET WIRE) -- February 22, 2007 -- Daxor Corporation (AMEX: DXR), a medical instrumentation and biotechnology company, today announced the receipt of a signed trial agreement from the Kaiser Permanente Los Angeles Medical Center, Los Angeles, California.
